ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Randall C. Starling
Jae K. Oh
Michael A. Acker
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starling, R. C.
Right arrow Articles by Kubo, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Starling, R. C.
Right arrow Articles by Kubo, S. H.
Related Collections
Right arrow Congestive Heart Failure
Right arrow Valve disease
Right arrowRelated Article

Ann Thorac Surg 2007;84:1236-1242
© 2007 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Sustained Benefits of the CorCap Cardiac Support Device on Left Ventricular Remodeling: Three Year Follow-up Results From the Acorn Clinical Trial

Randall C. Starling, MD, MPHa,*,*, Mariell Jessup, MDb, Jae K. Oh, MDd, Hani N. Sabbah, PhD, ACCe, Michael A. Acker, MDc, Douglas L. Mann, MDf, Spencer H. Kubo, MD, FACCg

a The Cleveland Clinic, Kaufman Center for Heart Failure, Cleveland, Ohio
b Department of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania
c Department of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
d Department of Cardiology, Mayo Clinic, Rochester, Minnesota
e Department of Cardiology, Henry Ford Health System, Detroit, Michigan
f Department of Cardiology, Baylor College of Medicine, Houston, Texas
g Acorn Cardiovascular Inc, St. Paul, Minnesota

Accepted for publication March 20, 2007.

* Address reprint requests to Dr Starling, Section of Heart Failure and Cardiac Transplant Medicine, Cleveland Clinic, Department of Cardiovascular Medicine, Desk F-25, 9500 Euclid Avenue, Cleveland, OH 44195 (Email: starlir{at}ccf.org).

Background: The objective of this study was to assess the long-term effects of the CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, MN) on left ventricular (LV) structure and function in patients with heart failure. Cardiac support devices, which reduce LV wall stress, have been shown to promote reverse remodeling in three different experimental models of heart failure. However, long-term effects in patients with heart failure have not been reported.

Methods: We enrolled 300 patients with heart failure in the Acorn Randomized Trial, as previously reported (Ann Thorac Surg 2007;84:1226–35). Echocardiograms were obtained every six months until the last patient was followed for one year, and then annually thereafter. Standard measurements of LV volumes, ejection fraction, and sphericity index were made by a Core laboratory at the Mayo Clinic who were blinded to treatment assignment.

Results: Patients treated with the CorCap Cardiac Support Device had significant reductions in LV end diastolic volume (average difference 18.8 mL; p = 0.005) and LV end systolic volume (average difference 15.6 mL; p = 0.013) compared with the control group. Sphericity index was significantly increased in the treatment group (average difference 0.045 units; p = 0.018). These changes were maintained over three years of follow-up. The improvements in LV size and shape were observed when the CorCap was implanted concomitantly with mitral value surgery or by itself.

Conclusions: These results demonstrate that the CorCap Cardiac Support Device has a long-term beneficial impact on LV size and shape in patients with heart failure.


Related Article

Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy
Douglas L. Mann, Michael A. Acker, Mariell Jessup, Hani N. Sabbah, Randall C. Starling, and Spencer H. Kubo
Ann. Thorac. Surg. 2007 84: 1226-1235. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Nicolini and T. Gherli
Alternatives to transplantation in the surgical therapy for heart failure
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
R. K. Ghanta, L. S. Lee, R. Umakanthan, R. G. Laurence, J. A. Fox, R. M. Bolman III, L. H. Cohn, and F. Y. Chen
Real-time adjustment of ventricular restraint therapy in heart failure
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1136 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1671 - 1678.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Masuyama, A. Marui, T. Shimamoto, M. Nonaka, M. Tsukiji, N. Watanabe, T. Ikeda, K. Yoshida, and M. Komeda
Chordal translocation for ischemic mitral regurgitation may ameliorate tethering of the posterior and anterior mitral leaflets.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 868 - 875.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.